14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BEAM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Friday for Beam Therapeutics Inc.
(Updated on May 17, 2024)

Hold candidate since May 16, 2024 Gain 3.49% PDF

The Beam Therapeutics Inc. stock price gained 3.49% on the last trading day (Friday, 17th May 2024), rising from $23.79 to $24.62. During the last trading day the stock fluctuated 6.97% from a day low at $23.24 to a day high of $24.86. The price has fallen in 6 of the last 10 days but is still up by 6.44% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 628 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $28.72 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -41.89% during the next 3 months and, with a 90% probability hold a price between $9.95 and $15.75 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BEAM Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, April 30, 2024, and so far it has risen 16.02%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Beam Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $24.81. On a fall, the stock will find some support from the short-term average at $23.45. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Beam Therapeutics Inc. stock

Beam Therapeutics Inc. finds support from accumulated volume at $24.31 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.62 between high and low, or 6.97%. For the last week, the stock has had daily average volatility of 8.04%.

Our recommended stop-loss: $23.70 (-3.74%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (BEAM) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Beam Therapeutics Inc. to open at $24.24, and during the day (based on 14 day Average True Range), to move between $23.03 and $26.21, which gives a possible trading interval of +/-$1.59 (+/-6.46%) up or down from last closing price. If Beam Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 12.93% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $24.31 (1.26%) than the resistance at $25.70 (4.39%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Beam Therapeutics Inc. stock A Buy?

Beam Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.611 Hold/Accumulate Unchanged

Predicted Opening Price for Beam Therapeutics Inc. of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
$24.24 ( 1.54%) $24.62

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BEAM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 25.86 5.04 %
R2 25.24 2.52 %
R1 24.86 0.97 %
Current price: 24.62
Support S1 23.62 -4.06 %
S2 23.24 -5.61 %
S3 22.62 -8.12 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 30.55 24.09 %
R2 27.06 9.91 %
R1 25.70 4.39 %
Current price 24.62
Support S1 24.31 -1.26%
S2 24.10 -2.11%
S3 23.90 -2.92%

BEAM Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 22, 2014 Feb 04, 2014 Mar 03, 2014 $0.225 0%
2 Sep 19, 2013 Nov 04, 2013 Dec 02, 2013 $0.225 0%
3 Jul 31, 2013 Aug 12, 2013 Sep 03, 2013 $0.225 0%
4 Apr 24, 2013 May 06, 2013 Jun 03, 2013 $0.225 0%
5 Jan 28, 2013 Feb 04, 2013 Mar 01, 2013 $0.225 0%

FAQ

What is the symbol for Beam Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Beam Therapeutics Inc. is BEAM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Beam Therapeutics Inc. Stock?
Beam Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Beam Therapeutics Inc. Stock?
Beam Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Beam Therapeutics Inc. Stock.

What's the current price of Beam Therapeutics Inc. Stock?
As of the end of day on the May 17, 2024, the price of an Beam Therapeutics Inc. (BEAM) share was $24.62.

What is the 52-week high and low for Beam Therapeutics Inc. Stock?
The 52-week high for Beam Therapeutics Inc. Stock is $49.50 and the 52-week low is $16.95.

What is the market capitalization of Beam Therapeutics Inc. Stock?
As of the May 17, 2024, the market capitalization of Beam Therapeutics Inc. is 2.026B.

When is the next earnings date for Beam Therapeutics Inc.?
The upcoming earnings date for Beam Therapeutics Inc. is Aug 13, 2024.
Click to get the best stock tips daily for free!

About Beam Therapeutics Inc.

Beam Therapeutics. Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-... BEAM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT